Zevra Therapeutics, Inc. (ZVRA)

11.56 -2.41% (-0.29)

Over 5Y: +25.7%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 10 15
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 2.9M Q3 '23 — Operating Cash Flow: -4.6M Q3 '23 — Free Cash Flow: -4.8M Q3 '23 — Net Income: -10.4M Q4 '23 — Revenue: 12.9M Q4 '23 — Operating Cash Flow: -16.2M Q4 '23 — Free Cash Flow: -16.2M Q4 '23 — Net Income: -19.9M Q1 '24 — Revenue: 3.4M Q1 '24 — Operating Cash Flow: -16.2M Q1 '24 — Free Cash Flow: -16.2M Q1 '24 — Net Income: -16.6M Q2 '24 — Revenue: 4.4M Q2 '24 — Operating Cash Flow: -19.1M Q2 '24 — Free Cash Flow: -19.1M Q2 '24 — Net Income: -19.9M Q3 '24 — Revenue: 3.7M Q3 '24 — Operating Cash Flow: -18.1M Q3 '24 — Free Cash Flow: -18.1M Q3 '24 — Net Income: -33.2M Q4 '24 — Revenue: 12M Q4 '24 — Operating Cash Flow: -16.2M Q4 '24 — Free Cash Flow: -16.2M Q4 '24 — Net Income: -35.7M Q1 '25 — Revenue: 20.4M Q1 '25 — Operating Cash Flow: -8.2M Q1 '25 — Free Cash Flow: -8.3M Q1 '25 — Net Income: -3.1M Q2 '25 — Revenue: 25.9M Q2 '25 — Operating Cash Flow: -3.6M Q2 '25 — Free Cash Flow: -3.8M Q2 '25 — Net Income: 74.7M Q3 '25 — Revenue: 26.1M Q3 '25 — Operating Cash Flow: 4.7M Q3 '25 — Free Cash Flow: 4.2M Q3 '25 — Net Income: -544K Q4 '25 — Revenue: 34.1M Q4 '25 — Operating Cash Flow: 5.5M Q4 '25 — Free Cash Flow: 5.5M Q4 '25 — Net Income: 12.2M Q1 '26 — Revenue: 36.2M Q1 '26 — Operating Cash Flow: 6.1M Q1 '26 — Free Cash Flow: 6.1M Q1 '26 — Net Income: 37.9M Q2 '26 — Revenue: 39.7M Q2 '26 — Operating Cash Flow: 17M Q2 '26 — Free Cash Flow: 16.8M Q2 '26 — Net Income: 8.8M -25M 0 25M 50M 75M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

8.6
Oper. margin 60.5%
ROIC 112.2%
OE margin 14.3%
Gross margin 94.4%
ROA 19.2%
ROCE 32.4%
ROE 26.8%
FCF margin 24.0%
OCF margin 24.5%
Accruals 8.2%
OCF / EBIT 0.41×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.7
ND/EBITDA —
Cash / Debt 3.6×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 5.1×
Debt / Eq 0.28×
F-score 6.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

8.8
Sales/sh Y/Y +77.2%
Sales CAGR 4Y +38.8%
EPS Y/Y +1679.6%
Sales Q/Q +53.3%
Shares change +23.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.